Vimarsana
Biggest News Aggregation in the World

Page 5 - David Misler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Misler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Misler Today - Breaking & Trending Today

SEC Charges Seven Individuals For $45 Million Fraudulent Scheme - Vimarsana News

SEC Charges Seven Individuals For $45 Million Fraudulent Scheme

<p><span>The Securities and Exchange Commission today charged seven individuals and a technology company in connection with a fraudulent scheme to gain control of Airborne Wireless Network, promote its stock, and defraud investors.</span></p>

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device - Vimarsana News

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device Washington, D.C.--(Newsfile Corp. - December 18, 2020) - The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 20...

SEC.gov | SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device - Vimarsana News

SEC.gov | SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device

FOR IMMEDIATE RELEASE Washington D.C., Dec. 18, 2020 — The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020. The SEC's complaint alleges that Decision Diagnostics and Berman ...

Source: sec.gov